EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical manifestations and analytical reports for MDPHP acute intoxication cases

Davide Arillotta, Arianna Totti, Alexandra Dimitrova, Emma B Croce, Maria Grazia Di Milia, Francesco Gambassi, Barbara Gualco, Giuseppe Pieraccini, Guido Mannaioni, Fabio Vaiano

Journal of Pharmaceutical and Biomedical Analysis · 2024

DOI: 10.1016/j.jpba.2024.115974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024. Verfasst von Davide Arillotta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, It…. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Rhabdomyolysis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MDPHP is a synthetic cathinone (SC) belonging to α-pyrrolidinophenone derivatives. It is a central nervous system stimulant and may induce hallucinations, paranoia, tachycardia, hypertension, chest pain, and rhabdomyolysis. In literature, a few cases of intoxication have been reported. In the present study, 17 cases of MDPHP intake were described including the analytical findings and clinical manifestations. MDPHP was quantified by liquid chromatography-tandem mass spectrometry in blood (range 1.26-73.30 ng/mL) and urine (range 19.31-8769.64 ng/mL) samples. In three cases the presence of α-PHP was observed. In one case, MDPHP was the only detected substance. Concomitant use of MDPHP with other substances, particularly psychostimulants, was common and it was difficult to describe the peculiar clinical characteristics of this SC. Most of the symptoms overlapped those expected, some of them were unusual and all of them particularly severe thus inducing the research of NPS in laboratory tests. We demonstrated the presence of psychiatric, neurological, and respiratory symptoms, as well as the possible presence of rhabdomyolysis and cardiotoxicity associated with the use of MDPHP. ED admissions were also more frequent in patients with addiction problems. In some cases, MDPHP intake required intensive supportive care. A multidisciplinary approach, including specialist consultation, is recommended for patients showing challenging features. Moreover, we demonstrated that the adoption of advanced analytical techniques, i.e., liquid chromatography-tandem mass spectrometry, is necessary to detect these molecules. Further studies are needed to understand MDPHP intake patterns and associated symptoms. It is essential to raise awareness in addiction treatment centers and among potential users, especially young people, and chemsex addicted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System StimulantsRhabdomyolysisHumansAdolescentSynthetic CathinoneMass SpectrometryChromatography, Liquid

Stichwörter der Autor:innen

Acute intoxicationChemsexLC-MS/MSMDPHPSynthetic cathinone

Substanzen

Central Nervous System StimulantsSynthetic Cathinone

Autor:innen und Institutionen

  • Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
  • Toxicology Unit, Poison Control Center, Careggi University Hospital, Florence, Italy.
  • FT-LAB Forensic Toxicology Laboratory, Department of Health Science, University of Florence, Florence, Italy.
  • Department of Health Science, University of Florence, Florence, Italy.
  • CISM Mass Spectrometry Center, University of Florence, Florence, Italy.
  • FT-LAB Forensic Toxicology Laboratory, Department of Health Science, University of Florence, Florence, Italy. Electronic address: fabio.vaiano@unifi.it.

Zitieren

APA

Arillotta, D., Totti, A., Dimitrova, A., Croce, E. B., Di Milia, M. G., Gambassi, F., Gualco, B., Pieraccini, G., Mannaioni, G., & Vaiano, F. (2024). Clinical manifestations and analytical reports for MDPHP acute intoxication cases. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.115974

Vancouver

Arillotta D, Totti A, Dimitrova A, Croce EB, Di Milia MG, Gambassi F, et al. Clinical manifestations and analytical reports for MDPHP acute intoxication cases. Journal of Pharmaceutical and Biomedical Analysis. 2024. doi:10.1016/j.jpba.2024.115974

BibTeX
@article{Arillotta2024,
  author = {Arillotta, Davide and Totti, Arianna and Dimitrova, Alexandra and Croce, Emma B and Di Milia, Maria Grazia and Gambassi, Francesco and Gualco, Barbara and Pieraccini, Giuseppe and Mannaioni, Guido and Vaiano, Fabio},
  title = {Clinical manifestations and analytical reports for MDPHP acute intoxication cases},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2024},
  doi = {10.1016/j.jpba.2024.115974}
}
Kostenlos starten →